Metlife INC Form 4 insider transactions

Director Edward J. Kelly III reports acquiring 265 shares of MetLife common stock through dividend reinvestment.

Director Diana McKenzie reports the acquisition of 146 shares of MetLife common stock through dividend reinvestment.

Director Jeh C. Johnson reported acquiring 30 shares of MetLife common stock through dividend reinvestment.

Director Robert Glenn Hubbard acquired additional MetLife shares through dividend reinvestment in the company's deferred compensation plan.

Director David L. Herzog reported acquiring 47 shares of MetLife common stock through dividend reinvestment.

Director Cheryl W. Grise reports acquiring 623 shares of MetLife common stock through dividend reinvestment.

Director Laura J. Hay acquired 594 shares of MetLife common stock at $73.69 per share on April 1, 2024, under the company's deferred compensation plan for non-management directors.

Director David L. Herzog reports changes in beneficial ownership of MetLife common stock, including acquisition through director compensation and disposal.

Director Denise M. Morrison acquired 594 shares of MetLife common stock on April 1, 2024, as part of the company's non-management director compensation arrangements.

Director Robert Glenn Hubbard acquired 1,018 shares of MetLife common stock at $73.69 per share under the company's deferred compensation plan.

Director William E. Kennard reports acquiring 594 shares of MetLife common stock at $73.69 per share on April 1, 2024.

Director Gerald L. Hassell acquired 594 shares of MetLife common stock at $73.69 per share under the company's deferred compensation plan.

Director Jeh C. Johnson acquired 594 shares of MetLife common stock on April 1, 2024, under the company's deferred compensation plan for non-management directors.

Director Carla A. Harris acquired 594 shares of MetLife common stock at $73.69 per share on April 1, 2024, and disposed of 5,600 shares.

Director Carlos M. Gutierrez reports acquiring and disposing of MetLife Inc. common stock on April 1, 2024.

Director Diana McKenzie acquired 594 shares of MetLife common stock at $73.69 per share on April 1, 2024, and now beneficially owns 18,550 shares.

Catherine R. Kinney, a director at MetLife, acquired 594 shares of common stock on April 1, 2024, as part of the company's non-management director compensation arrangements.

Director Cheryl W. Grise acquired 594 shares of MetLife common stock at $73.69 per share under the company's deferred compensation plan.

Director Edward J. Kelly III acquired 594 shares of MetLife common stock at $73.69 per share on April 1, 2024, through the company's deferred compensation plan.

Director Mark A. Weinberger acquired 594 shares of MetLife common stock on April 1, 2024, as part of the company's non-management director compensation arrangements.

Bill Pappas, EVP of Global Technology & Operations at MetLife, sold 27,000 shares of common stock on March 18, 2024, at an average price of $72.2713.

Director Gerald L. Hassell reported acquiring 148 shares of MetLife common stock through dividend reinvestment.

Catherine R. Kinney, a director of MetLife, Inc., reported the acquisition of 263 shares of common stock at a price of $71.9 on March 14, 2024, bringing her total holdings to 60,932 shares.

Director Carla A. Harris reported the acquisition of 5 shares of MetLife common stock through dividend reinvestment.

Director Cheryl W. Grise acquired 562 shares of MetLife common stock through dividend reinvestment at a price of $71.90 per share.

Director Robert Glenn Hubbard acquired 600 shares of MetLife (MET) at $71.90 per share, increasing his total holdings to 91,523 shares.

Director Edward J. Kelly III reports acquiring 237 shares of MetLife common stock through dividend reinvestment.

Director Diana McKenzie reported the acquisition of 129 shares of MetLife common stock through dividend reinvestment.

Director Jeh C. Johnson reports a transaction involving MetLife common stock, reflecting an imputed reinvestment of dividends on deferred shares.

Director David L. Herzog increased his holdings in MetLife through a dividend reinvestment in the company's deferred compensation plan.